IgM myeloma: More on a rare entity

British Journal of Haematology

Volumn 143, Issue 1, 2008, Pages 146-148

  Willenbacher, E ^a   Erdel, M ^b   Strasser, U ^c   Gastl, G ^a   Schmidt, S ^a   Gunsilius, E ^a   Willenbacher, W ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Bortezomib; Cytogenetics; del13; IGH rearrangement; IgM myeloma; T(11; 14)

Indexed keywords

BORTEZOMIB; DEXAMETHASONE; IMMUNOGLOBULIN M; PARAPROTEIN;

ADULT; AGED; BONE LESION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CLINICAL FEATURE; FEMALE; HUMAN; LETTER; MALE; MULTIPLE CYCLE TREATMENT; MYELOMA; PRIORITY JOURNAL; RARE DISEASE; TREATMENT RESPONSE;

GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTIPLE MYELOMA;

EID: 51249121293     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07313.x     Document Type: Letter

References (2)

1. - immunophenotype and the t(11;14). BJH, 140, 547 551. doi:.
2. Richardson, P.G., Sonneveld, P., Schuster, M.W., Irwin, D., Stadtmauer, E.A., Facon, T., Harousseau, J.L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., San-Miguel, J.F., Bladé, J., Boccadoro, M., Cavenagh, J., Dalton, W.S., Boral, A.L., Esseltine, D.L., Porter, J.B., Schenkein, D., Anderson, K.C. Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators 2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. NEJM, 352, 2487 2498.